[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 54, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 41.39, "open": 39.7, "dayLow": 37.25, "dayHigh": 42.68, "regularMarketPreviousClose": 41.39, "regularMarketOpen": 39.7, "regularMarketDayLow": 37.25, "regularMarketDayHigh": 42.68, "payoutRatio": 0.0, "beta": 1.194, "forwardPE": -17.088985, "volume": 17602, "regularMarketVolume": 17602, "averageVolume": 51191, "averageVolume10days": 31090, "averageDailyVolume10Day": 31090, "bid": 40.05, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 246115040, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 54.3, "fiftyDayAverage": 38.0846, "twoHundredDayAverage": 17.3288, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 206833424, "profitMargins": 0.0, "floatShares": 2994199, "sharesOutstanding": 6102530, "sharesShort": 50687, "sharesShortPriorMonth": 32525, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.3731, "heldPercentInstitutions": 0.4225, "shortRatio": 1.3, "shortPercentOfFloat": 0.0165, "impliedSharesOutstanding": 6102530, "bookValue": 1.403, "priceToBook": 28.745546, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -6474726, "trailingEps": -1.98, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 10.879234, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 40.33, "targetHighPrice": 76.0, "targetLowPrice": 37.0, "targetMeanPrice": 53.25, "targetMedianPrice": 50.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 6020084, "totalCashPerShare": 1.141, "totalDebt": 0, "quickRatio": 5.361, "currentRatio": 5.405, "returnOnAssets": -0.59667, "returnOnEquity": -1.12038, "freeCashflow": -3873349, "operatingCashflow": -5951620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekChangePercent": 1087.9235, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.98, "epsForward": -2.36, "epsCurrentYear": -1.77333, "priceEpsCurrentYear": -22.742525, "fiftyDayAverageChange": 2.2454033, "fiftyDayAverageChangePercent": 0.058958303, "twoHundredDayAverageChange": 23.001202, "twoHundredDayAverageChangePercent": 1.3273395, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "Monopar Therapeutics Inc.", "regularMarketChangePercent": -2.5609992, "regularMarketPrice": 40.33, "corporateActions": [], "postMarketTime": 1743194943, "regularMarketTime": 1743192001, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "longName": "Monopar Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": 3.91767, "postMarketPrice": 41.91, "postMarketChange": 1.58, "regularMarketChange": -1.0599976, "regularMarketDayRange": "37.25 - 42.68", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 51191, "fiftyTwoWeekLowChange": 38.61, "fiftyTwoWeekLowChangePercent": 22.447674, "fiftyTwoWeekRange": "1.72 - 54.3", "fiftyTwoWeekHighChange": -13.969997, "fiftyTwoWeekHighChangePercent": -0.25727436, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]